Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

If the 8-K omitted royalties for sales.....

That would mean MacLellan failed to grasp an opportunity to pump his stock in an 8-K by neglecting to describe $$$ coming into the Radient coffers. Not just ONCE, but AGAIN in the amended 8-K.

Are we talking about the same MacLellan? Because that does not sound like the Doug McLellan that is CEO of Radient Pharmaceuticals.

MacLellan adds immaterial fluff to his 8-K's to try and pump his stock the way he used to pump the stock in press releases. But in this case, the theory is that he left out something not merely MATERIAL but potentially more profitable than the $500,000 licensing royalties.

Pinksheet "investing" is gambling, pure and simple. Betting your money on MacLellan making that kind of omission in the 8-K and again in the 8-K/A seems like a poor bet to me.

Reading between the lines of a press release is often necessary. Reading between the lines of an 8-K is folly.